A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Zoetis Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 343,969 shares of ZTS stock, worth $60.9 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
343,969
Previous 316,545 8.66%
Holding current value
$60.9 Million
Previous $54.9 Million 22.47%
% of portfolio
0.31%
Previous 0.26%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$172.58 - $196.48 $4.73 Million - $5.39 Million
27,424 Added 8.66%
343,969 $67.2 Million
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $32.6 Million - $40 Million
223,907 Added 241.7%
316,545 $54.9 Million
Q1 2024

May 13, 2024

SELL
$165.67 - $199.94 $165,504 - $199,740
-999 Reduced 1.07%
92,638 $15.7 Million
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $321,204 - $424,390
2,121 Added 2.32%
93,637 $18.5 Million
Q3 2023

Nov 09, 2023

SELL
$167.14 - $192.77 $100,785 - $116,240
-603 Reduced 0.65%
91,516 $15.9 Million
Q2 2023

Aug 07, 2023

BUY
$160.94 - $186.23 $1.34 Million - $1.55 Million
8,301 Added 9.9%
92,119 $15.9 Million
Q1 2023

May 11, 2023

SELL
$145.48 - $175.02 $135,441 - $162,943
-931 Reduced 1.1%
83,818 $14 Million
Q4 2022

Feb 08, 2023

SELL
$131.14 - $157.47 $116,845 - $140,305
-891 Reduced 1.04%
84,749 $12.4 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $113,145 - $139,285
-763 Reduced 0.88%
85,640 $12.7 Million
Q2 2022

Aug 10, 2022

SELL
$155.97 - $200.09 $1.61 Million - $2.06 Million
-10,314 Reduced 10.66%
86,403 $14.9 Million
Q1 2022

May 11, 2022

SELL
$181.39 - $234.03 $16.6 Million - $21.4 Million
-91,551 Reduced 48.63%
96,717 $18.2 Million
Q4 2021

Feb 10, 2022

SELL
$193.69 - $247.03 $17.9 Million - $22.9 Million
-92,547 Reduced 32.96%
188,268 $46.2 Million
Q3 2021

Nov 10, 2021

SELL
$189.29 - $209.69 $351,890 - $389,813
-1,859 Reduced 0.66%
280,815 $54.5 Million
Q2 2021

Aug 10, 2021

BUY
$155.9 - $187.99 $9.48 Million - $11.4 Million
60,804 Added 27.41%
282,674 $52.7 Million
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $12.7 Million - $15 Million
88,275 Added 66.08%
221,870 $34.9 Million
Q4 2020

Feb 11, 2021

BUY
$157.07 - $174.35 $3.79 Million - $4.2 Million
24,116 Added 22.03%
133,595 $22.1 Million
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $447,631 - $539,933
3,265 Added 3.07%
109,479 $18.1 Million
Q2 2020

Aug 13, 2020

BUY
$111.92 - $142.53 $27,196 - $34,634
243 Added 0.23%
106,214 $14.6 Million
Q1 2020

May 13, 2020

SELL
$92.66 - $144.94 $34.4 Million - $53.8 Million
-371,250 Reduced 77.79%
105,971 $12.5 Million
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $61,961 - $71,022
-533 Reduced 0.11%
477,221 $63.2 Million
Q3 2019

Nov 08, 2019

SELL
$112.57 - $128.43 $5.33 Million - $6.08 Million
-47,304 Reduced 9.01%
477,754 $59.5 Million
Q2 2019

Aug 09, 2019

SELL
$97.98 - $114.28 $4.06 Million - $4.74 Million
-41,470 Reduced 7.32%
525,058 $59.6 Million
Q1 2019

May 15, 2019

BUY
$81.56 - $100.67 $9.59 Million - $11.8 Million
117,529 Added 26.18%
566,528 $57 Million
Q4 2018

Feb 12, 2019

SELL
$79.28 - $95.27 $6.05 Million - $7.27 Million
-76,351 Reduced 14.53%
448,999 $38.4 Million
Q3 2018

Nov 05, 2018

SELL
$83.5 - $93.23 $5.44 Million - $6.08 Million
-65,200 Reduced 11.04%
525,350 $48.1 Million
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $2.3 Million - $2.56 Million
28,726 Added 5.11%
590,550 $50.3 Million
Q1 2018

Apr 30, 2018

BUY
$71.51 - $84.69 $22.3 Million - $26.4 Million
311,798 Added 124.71%
561,824 $46.9 Million
Q4 2017

Feb 12, 2018

SELL
$63.24 - $72.8 $246,636 - $283,920
-3,900 Reduced 1.54%
250,026 $18 Million
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $340,461 - $372,780
5,700 Added 2.3%
253,926 $16.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
248,226
248,226 $0

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.